P53-induced protein with a death domain (PIDD): master of puppets?

Por Bock, FJ, Peintner, L, Tanzer, M, Manzl, C, Villunger, A
Publicado no Oncogene (2012)

The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd

Por Peintner, L, Dorstyn, L, Kumar, S, Aneichyk, T, Villunger, A, Manzl, C
Publicado no Cell Death Differ (2015)

9th Tuscany Retreat on Cancer Research: genetic profiling, resistance mechanisms and novel treatment concepts in cancer

Por Peintner, L, Novelli, F, Smirnov, A, Maurer, U, Borner, C, von Karstedt, S
Publicado no Cell Death Differ (2016)

PIDDosome-independent tumor suppression by Caspase-2

Por Manzl, C, Peintner, L, Krumschnabel, G, Bock, F, Labi, V, Drach, M, Newbold, A, Johnstone, R, Villunger, Andreas
Publicado em 2012

Loss of PIDD limits NF-κB activation and cytokine production but not cell survival or transformation after DNA damage

Por Bock, F J, Krumschnabel, G, Manzl, C, Peintner, L, Tanzer, M C, Hermann-Kleiter, N, Baier, G, Llacuna, L, Yelamos, J, Villunger, A
Publicado em 2013

Death of p53-defective cells triggered by forced mitotic entry in the presence of DNA damage is not uniquely dependent on Caspase-2 or the PIDDosome

Por Manzl, C, Fava, L L, Krumschnabel, G, Peintner, L, Tanzer, M C, Soratroi, C, Bock, F J, Schuler, F, Luef, B, Geley, S, Villunger, A
Publicado em 2013